The purpose of this study is to compare the 4-year biochemical
disease-free survival (BDFS) of patients with prostate cancer
(PCa) staged according to multiparametric MRI (mpMRI) and
treated with radical prostatectomy (RP) versus intensity-modulated
radiation therapy (IMRT) ≥76 Gy ± hormonal therapy (HT).